The Commodore 64 Ultimate is the most astonishing retro product I have ever reviewed. I was expecting it to be a straightforward, modern take on the all-time best-selling personal computer. I imagined ...

Shares of blood products company Haemonetics (NYSE:HAE). fell 2.1% in the morning session after Citigroup downgraded the stock to "Neutral" from "Buy." The action came from analyst Joanne Wuensch.

Deucrictibant shows rapid symptom relief and strong safety profile in RAPIDe-3 study Pharvaris has announced positive topline data from its RAPIDe-3 pivotal phase 3 study, confirming the potential of ...

Shin Hae Sun and Na In Woo may be teaming up for a new romantic comedy! On November 18, OSEN and MyDaily reported that Shin Hae Sun and Na In Woo will be starring in the upcoming Netflix original ...

Haemonetics (HAE) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $1.12 per share a year ago. These figures ...

Living with hereditary angioedema (HAE) means navigating a rare condition that causes painful swelling in various parts of the body, often including the face, hands, feet, genitals, abdomen, and ...

KalVista Pharmaceuticals remains a Hold as the stock underperforms post-Ekterly launch, reflecting challenges in the hereditary angioedema (HAE) market. Ekterly's commercial debut faces headwinds from ...

Since 2008, the FDA has approved 11 treatments for a rare genetic condition called hereditary angioedema (HAE), with three of the nods coming in the last two months. The latest drug to join this ...

A new survey reveals that nearly 80% of ITAM and SAM professionals are moving away from Oracle Java, citing cost hikes, audit risks, and licensing confusion as key drivers. Nearly 8 in 10 ...

Back in January 1982, we were treated to the launch of the Commodore 64, an early computer that was bought by millions of users around the world across 12 years, which is now fondly remembered by ...

Anti-factor XIIa biologic garadacimab (Andembry) got the FDA greenlight for use in preventing hereditary angioedema (HAE) attacks in adult and pediatric patients ages 12 years and older, CSL announced ...